A new type of treatment significantly reduces the severity of muscle weakness in myasthenia gravis (MG), giving hope for a new class of drugs to treat neurological disorders, according to a study published in the August 14, 2007, issue of Neurology?, the medical journal of the American Academy of Neurology.
September 9th is National Grandparents Day, a day to honor grandparents across America as important members of our families and communities. Grandparents play important roles in life, including that of guardian, comforter, and mentor.
Two new studies may lead to the development of more effective therapies for individuals with multiple myeloma (MM), a common and incurable blood cell cancer.
In an editorial, to be published in the international journal Osteoarthritis and Cartilage, published by Elsevier, a panel of arthritis research experts has recommended that coxibs and nonsteroidal anti-inflammatory drugs must remain a significant part of the tool kit used in treating osteoarthritis.
Patients with advanced kidney cancer and gastrointestinal stromal tumours in British Columbia will be the first in Canada to benefit from coverage for the medication Sutent (sunitinib) or Nexavar (sorafenib), announced Health Minister George Abbott today.
Abbott has received a supplemental Premarket Approval from the U.S. Food and Drug Administration for its recently introduced RealTime HIV-1 viral load test.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Solvay Pharmaceuticals, Inc. announced the receipt of an action letter from the U.S. Food and Drug Administration (FDA) in response to the New Drug Application (NDA) for bifeprunox, an atypical antipsychotic that was reviewed for the acute treatment of schizophrenia, as well as the maintenance of stable adult patients.
Women going through menopause gain on average of one pound of body weight each year. New research reveals, however, that efforts to minimize or reverse this trend have the undesirable side effect of decreasing bone mineral density (BMD), putting those who are most successful at controlling weight gain at greater risk of osteoporosis.
When a woman receives a breast cancer diagnosis her entire life may change in the blink of an eye. But the nature of that change is governed by the smallest alterations that take place within the proteins of the tumor cells, determining what treatments she can pursue with a hope of cure and those to which her cancer is resistant.
In a study published in the August issue of Nature Neuroscience, researchers at the Kennedy Krieger Institute in Baltimore, Maryland found that there are separate adaptable networks controlling each leg and there are also separate networks controlling leg movements, e.g., forward or backward walking.